Analysts
Scores, price targets and rating changes published by the firms we track. Informational, not advice.
Price target forecast
The average analyst target through the past year, and where analysts see the price a year from now.
Nov 6, 20263 analyst targets · 90 days
- Share price
- $11.91
- Average 1Y price target
- $18.67+56.76%
- Agreement
- Fair
Analysts agreement range is spread 15% to 30% from the average
Share priceAverage analyst target (90-day window), shaded 10th–90th percentile12-month range from the lowest to the highest current target, dashed to the average
Rating scores
Each factor is scored 1 (weak) to 5 (strong).
- Overall3
- DCF3
- Return on equity4
- Return on assets3
- Debt / equity2
- P/E3
- P/B3
Average price target
Mean of the targets analysts published in each window.
| Window | Targets | Average |
|---|---|---|
| Last month | 1 | $14.00 |
| Last quarter | 3 | $18.67 |
| Last year | 5 | $19.20 |
| All time | 12 | $16.58 |
Recent rating changes
The latest 40 changes by research firm, newest first.
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 22, 2026 | Citizens | maintain | Market Outperform | Market Outperform |
| Oct 19, 2026 | Piper Sandler | downgrade | Overweight | Neutral |
| Oct 12, 2026 | Piper Sandler | maintain | Overweight | Overweight |
| Oct 9, 2026 | Keefe, Bruyette & Woods | maintain | Outperform | Outperform |
| Aug 17, 2026 | Barclays | maintain | Overweight | Overweight |
| May 1, 2026 | Keefe, Bruyette & Woods | maintain | Outperform | Outperform |
| May 1, 2026 | Citizens | maintain | Market Outperform | Market Outperform |
| Mar 13, 2026 | Barclays | maintain | Overweight | Overweight |
| Mar 2, 2026 | Keefe, Bruyette & Woods | maintain | Outperform | Outperform |
| Jan 8, 2026 | Keefe, Bruyette & Woods | maintain | Outperform | Outperform |
| Oct 9, 2025 | Keefe, Bruyette & Woods | maintain | Outperform | Outperform |
| Aug 4, 2025 | Piper Sandler | maintain | Overweight | Overweight |
| Jul 31, 2025 | JMP Securities | maintain | Market Outperform | Market Outperform |
| Jul 24, 2025 | Keefe, Bruyette & Woods | maintain | Outperform | Outperform |
| May 23, 2025 | Wolfe Research | upgrade | Peer Perform | Outperform |
| May 5, 2025 | Piper Sandler | maintain | Overweight | Overweight |
| May 2, 2025 | Keefe, Bruyette & Woods | maintain | Outperform | Outperform |
| Apr 17, 2025 | Keefe, Bruyette & Woods | maintain | Outperform | Outperform |
| Mar 19, 2025 | Goldman Sachs | maintain | Buy | Buy |
| Nov 25, 2024 | Wolfe Research | downgrade | Outperform | Peer Perform |
| Sep 5, 2024 | Keefe, Bruyette & Woods | upgrade | Market Perform | Outperform |
| Sep 3, 2024 | Piper Sandler | maintain | Overweight | Overweight |
| Aug 16, 2024 | Wolfe Research | upgrade | Peer Perform | Outperform |
| Aug 8, 2024 | Keefe, Bruyette & Woods | maintain | Market Perform | Market Perform |
| Jul 25, 2024 | Keefe, Bruyette & Woods | maintain | Market Perform | Market Perform |
| Mar 26, 2024 | Piper Sandler | maintain | Overweight | Overweight |
| Feb 26, 2024 | Keefe, Bruyette & Woods | maintain | Market Perform | Market Perform |
| Dec 20, 2023 | Piper Sandler | upgrade | Neutral | Overweight |
| Oct 4, 2023 | Raymond James | downgrade | Outperform | Market Perform |
| May 9, 2023 | Goldman Sachs | maintain | Sell | Sell |
| May 8, 2023 | Raymond James | maintain | Outperform | Outperform |
| May 8, 2023 | Piper Sandler | maintain | Neutral | Neutral |
| May 8, 2023 | Keefe, Bruyette & Woods | maintain | Market Perform | Market Perform |
| Apr 24, 2023 | Keefe, Bruyette & Woods | maintain | Market Perform | Market Perform |
| Apr 11, 2023 | Goldman Sachs | maintain | Sell | Sell |
| Apr 10, 2023 | Goldman Sachs | maintain | Sell | Sell |
| Feb 17, 2023 | Goldman Sachs | maintain | Sell | Sell |
| Jan 20, 2023 | Raymond James | maintain | Outperform | Outperform |
| Dec 12, 2022 | Goldman Sachs | downgrade | Neutral | Sell |
| Nov 8, 2022 | Goldman Sachs | maintain | Neutral | Neutral |